Written Question · S4W-01363 · Session 4
What representations it has received on access to Eculizumab for the treatment of paroxysmal nocturnal haemoglobinuria in the last year.
The question
To ask the Scottish Executive what representations it has received on access to Eculizumab for the treatment of paroxysmal nocturnal haemoglobinuria in the last year.
The answer
The Scottish Government has received a range of representations regarding the availability of eculizumab to treat paroxysmal nocturnal haemoglobinuria which includes letters from members of the public, patient representative groups and parliamentary questions.
In the Official Report
No contribution in the Official Report cites S4W-01363 by reference.